{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:47:20Z","timestamp":1792234040680,"version":"4.4.0"},"reference-count":30,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2025,4,30]]},"DOI":"10.5582\/ddt.2025.01032","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T22:07:39Z","timestamp":1746742059000},"page":"124-128","source":"Crossref","is-referenced-by-count":12,"title":["Can the herpes zoster vaccination be a strategy against dementia?"],"prefix":"10.5582","volume":"19","author":[{"given":"Ya-nan","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Karako","sequence":"additional","affiliation":[{"name":"Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Song","sequence":"additional","affiliation":[{"name":"Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan. 4 National College of Nursing Japan, Tokyo, Japan."},{"name":"National College of Nursing Japan, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China."},{"name":"Integrated Neuroscience Center, Geriatric Hospital of Hainan, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ma YN, Xia Y, Karako K, Song P, Tang W, Hu X. Serum proteomics reveals early biomarkers of Alzheimer&apos;s disease: The dual role of APOE-\u03b54. Biosci Trends. 2025; 19:1-9.","DOI":"10.5582\/bst.2024.01365"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Eyting M, Xie M, Michalik F, Hess S, Chung S, Geldsetzer P. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025. doi:10.1038\/s41586-025-08800-x","DOI":"10.1038\/s41586-025-08800-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Harris K, Ling Y, Bukhbinder AS, Chen L, Phelps KN, Cruz G, Thomas J, Kim Y, Jiang X, Schulz PE. The impact of routine vaccinations on Alzheimer&apos;s disease risk in persons 65 years and older: a claims-based cohort study using propensity score matching J Alzheimers Dis. 2023; 95:703-718.","DOI":"10.3233\/JAD-221231"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024; 30:2777-2781.","DOI":"10.1038\/s41591-024-03201-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tang E, Ray I, Arnold BF, Acharya NR. Recombinant zoster vaccine and the risk of dementia. Vaccine. 2025; 46:126673.","DOI":"10.1016\/j.vaccine.2024.126673"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lophatananon A, Carr M, McMillan B, Dobson C, Itzhaki R, Parisi R, Ashcroft DM, Muir KR. The association of herpes zoster and influenza vaccinations with the risk of developing dementia: A population-based cohort study within the UK Clinical Practice Research Datalink. BMC Public Health. 2023; 23:1903.","DOI":"10.1186\/s12889-023-16768-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lophatananon A, Mekli K, Cant R, Burns A, Dobson C, Itzhaki R, Muir K. Shingles, Zostavax vaccination and risk of developing dementia: A nested case-control study-results from the UK Biobank cohort. BMJ Open. 2021; 11:e045871.","DOI":"10.1136\/bmjopen-2020-045871"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lehrer S, Rheinstein PH. Herpes zoster vaccination reduces risk of dementia. In Vivo. 2021; 35:3271-3275.","DOI":"10.21873\/invivo.12622"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bae S, Yun SC, Kim MC, Yoon W, Lim JS, Lee SO, Choi SH, Kim YS, Woo JH, Kim SY, Kim SH. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: A population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021; 271:987-997.","DOI":"10.1007\/s00406-020-01157-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Warren-Gash C, Williamson E, Shiekh SI, Borjas-Howard J, Pearce N, Breuer JM, Smeeth L. No evidence that herpes zoster is associated with increased risk of dementia diagnosis. Ann Clin Transl Neurol. 2022; 9:363-374.","DOI":"10.1002\/acn3.51525"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Schmidt SAJ, Veres K, Sorensen HT, Obel N, Henderson VW. Incident herpes zoster and risk of dementia: a population-based Danish cohort study Neurology. 2022; 99:e660-e668.","DOI":"10.1212\/WNL.0000000000200709"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shah S, Dahal K, Thapa S, Subedi P, Paudel BS, Chand S, Salem A, Lammle M, Sah R, Krsak M. Herpes zoster vaccination and the risk of dementia: A systematic review and meta-analysis. Brain Behav. 2024; 14:e3415.","DOI":"10.1002\/brb3.3415"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007; 429:95-100.","DOI":"10.1016\/j.neulet.2007.09.077"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wozniak MA, Frost AL, Itzhaki RF. Alzheimer&apos;s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009; 16:341-350.","DOI":"10.3233\/JAD-2009-0963"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages <i>via<\/i> Toll-like receptor 2. J Virol. 2005; 79:12658-12666.","DOI":"10.1128\/JVI.79.20.12658-12666.2005"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shoji H, Umeda S, Kanazawa M, Koga N, Takaki H, Kitsuki S, Matsuoka M, Matsushita T, Fukushima Y, Fukuda K. Herpes zoster central nervous system complication: An increasing trend of acute limbic encephalitis. Intractable Rare Dis Res. 2025; 14:81-84.","DOI":"10.5582\/irdr.2025.01000"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Benn CS, Netea MG, Selin LK, Aaby P. A small jab - a big effect: Nonspecific immunomodulation by vaccines. Trends Immunol. 2013; 34:431-439.","DOI":"10.1016\/j.it.2013.04.004"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hakami MA, Khan FR, Abdulaziz O, Alshaghdali K, Hazazi A, Aleissi AF, Abalkhail A, Alotaibi BS, Alhazmi AYM, Kukreti N, Binshaya AS. Varicella-zoster virus-related neurological complications: From infection to immunomodulatory therapies. Rev Med Virol. 2024; 34:e2554.","DOI":"10.1002\/rmv.2554"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kennedy PG. Varicella-zoster virus latency in human ganglia. Rev Med Virol. 2002; 12:327-334.","DOI":"10.1002\/rmv.362"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kimura H, Futamura M, Kito H, Ando T, Goto M, Kuzushima K, Shibata M, Morishima T. Detection of viral DNA in neonatal herpes simplex virus infections: Frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis. 1991; 164:289-293.","DOI":"10.1093\/infdis\/164.2.289"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yue J, Yao M. Humoral cytokine levels in patients with herpes zoster: A meta-analysis. J Pain Res. 2024; 17:887-902.","DOI":"10.2147\/JPR.S449211"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Carpenter JE, Clayton AC, Halling KC, Bonthius DJ, Buckingham EM, Jackson W, Dotzler SM, Card JP, Enquist LW, Grose C. Defensive perimeter in the central nervous system: Predominance of astrocytes and astrogliosis during recovery from varicella-zoster virus encephalitis. J Virol. 2016; 90:379-391.","DOI":"10.1128\/JVI.02389-15"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Bubak AN, Como CN, Coughlan CM, Johnson NR, Hassell JE, Mescher T, Niemeyer CS, Mahalingam R, Cohrs RJ, Boyd TD, Potter H, Russ HA, Nagel MA. Varicella-zoster virus infection of primary human spinal astrocytes produces intracellular amylin, amyloid-beta, and an amyloidogenic extracellular environment. J Infect Dis. 2020; 221:1088-1097.","DOI":"10.1093\/infdis\/jiz560"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Itzhaki RF, Lathe R. Herpes viruses and senile dementia: First population evidence for a causal link. J Alzheimers Dis. 2018; 64:363-366.","DOI":"10.3233\/JAD-180266"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nour AM, Reichelt M, Ku CC, Ho MY, Heineman TC, Arvin AM. Varicella-zoster virus infection triggers formation of an interleukin-1beta (IL-1beta)-processing inflammasome complex. J Biol Chem. 2011; 286:17921-17933.","DOI":"10.1074\/jbc.M110.210575"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chen SY, Suaya JA, Li Q, Galindo CM, Misurski D, Burstin S, Levin MJ. Incidence of herpes zoster in patients with altered immune function. Infection. 2014; 42:325-334.","DOI":"10.1007\/s15010-013-0550-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Alvarez JC, Alvarez J, Tinoco J, Mellado P, Miranda H, Ferres M, Forero J, Alvarez C. Varicella-zoster virus meningitis and encephalitis: An understated cause of central nervous system infections. Cureus. 2020; 12:e11583.","DOI":"10.7759\/cureus.11583"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jang SO, Lee JH, Chung YJ, Oh HS, Shin M, Kim SO, Hong SP. Chimeric adenovirus-based herpes zoster vaccine with the tPA signal peptide elicits a robust T-cell immune response. Virology. 2024; 600:110243.","DOI":"10.1016\/j.virol.2024.110243"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Voic H, de Vries RD, Sidney J, Rubiro P, Moore E, Phillips E, Mallal S, Schwan B, Weiskopf D, Sette A, Grifoni A. Identification and characterization of CD4<sup>+<\/sup> T cell epitopes after Shingrix vaccination. J Virol. 2020; 94.","DOI":"10.1128\/JVI.01641-20"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Vuscan P, Kischkel B, Joosten LAB, Netea MG. Trained immunity: General and emerging concepts. Immunol Rev. 2024; 323:164-185.","DOI":"10.1111\/imr.13326"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/2\/19_2025.01032\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T04:20:13Z","timestamp":1746850813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/2\/19_2025.01032\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01032","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"article-number":"2025.01032"}}